✦ LIBER ✦

Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial

✍ Scribed by Remo Panccione; Subrata Ghosh; Stephen Middleton; Juan R. Marquez; Igor Khalif; Laurence Flint; Hubert van Hoogstraten; Hanzhe Zheng; Silvio Danese; Paul J. Rutgeerts

Book ID: 119432395
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 389 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60548-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1108 Cost-Effectiveness of Golimumab V

Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis

✍ Thorlund, Kristian; Druyts, Eric; Kanters, Steve; Eapen, Shawn; Mills, Edward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Long-term maintenance treatment of moder

Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort

✍ M Dalaker; JH Bonesrønning 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Mo1325 Cost-Effectiveness of Infliximab

Mo1325 Cost-Effectiveness of Infliximab Scheduled Maintenance Treatment for the Management of Patients With Moderate-to-Severe Ulcerative Colitis

✍ Monfared, Amir A. Tahami; Feagan, Brian G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 227 KB

P447 Infliximab in the treatment of mode

P447 Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey

✍ Cappello, M.; Mazza, M.; Costantino, G.; Fries, W.; Privitera, A.C.; Mastronardi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

T1139 The ACT Trials: Incremental Benefi

T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC)

✍ Sandborn, William J.; Rutgeerts, Paul J.; Feagan, Brian; Reinisch, Walter; Olson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

A model of the long-term cost effectiven

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

✍ H. H. TSAI; Y. S. PUNEKAR; J. MORRIS; P. FORTUN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB